Academic Journal
Q1Antimicrobial Agents and Chemotherapy
About Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy is a scholarly journal published by American Society for Microbiology. SCImago 2025 places it in Q1 with an SJR of 1.473 and an H-index of 309.
Its listed coverage is 1963-1970, 1972-2026 and its research categories include Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). The 2025 dataset reports 429 documents and 5700 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Antifungal resistance and susceptibility, Pneumonia and Respiratory Infections, Bacterial Identification and Susceptibility Testing.
Recent Research Articles
Latest publications matched automatically by ISSN.
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa
Preeti Garai, Sophia H. Nozick, Caroline C. Jozefczyk, Hannah Nam et al.
2026-09-04 · DOI: 10.1128/aac.00356-26Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial
Yuming Guo, Yonggang Li, Pan Zhao, Jingfeng Bi et al.
2026-09-04 · DOI: 10.1128/aac.00984-26Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients
Tavey Dorofaeff, María Patricia Hernández-Mitre, Xin Liu, Yarmarly C. Guerra Valero et al.
2026-09-03 · DOI: 10.1128/aac.00272-26In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States
Nathan P. Wiederhold, Charlotte Bisson, David A. Stevens, Chiung-Yu Hung et al.
2026-09-03 · DOI: 10.1128/aac.00744-26XAB06, a glyco-humanized broad-spectrum anti- Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model
Pierre-Joseph Royer, George Graur, Mehdi Varin, Bernard Vanhove et al.
2026-09-03 · DOI: 10.1128/aac.00277-26Rigor and reproducibility of hollow-fiber infection model for antiviral pharmacokinetics/pharmacodynamics studies
Shashikant Srivastava, Tawanda Gumbo
2026-09-03 · DOI: 10.1128/aac.00969-26Reply to Srivastava and Gumbo, “Rigor and reproducibility of hollow-fiber infection model for antiviral pharmacokinetics/pharmacodynamics studies”
Lalitya M. Sudarsono, Suzanne A. M. Wenker, Xuanlin Liu, Jorn Brink et al.
2026-09-03 · DOI: 10.1128/aac.00980-26Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa
Claire Han, Karishma Patel, Haoran Gao, Jacob T. Sanborn et al.
2026-09-03 · DOI: 10.1128/aac.00048-26Targeting SARS-CoV-2 programmed −1 ribosomal frameshifting: structural dynamics and RNA-directed antiviral strategies
Neha Jeena, Inshad Ali Khan
2026-09-02 · DOI: 10.1128/aac.00687-26Extension of penA diversity within the genus Neisseria : characterization of a penA/ftsI homolog in Neisseria bacilliformis associated with elevated ceftriaxone MICs
Sheeba Santhini Manoharan-Basil, Tessa de Block, Izumo Kanesaka, Saïd Abdellati et al.
2026-09-02 · DOI: 10.1128/aac.00392-26Establishment of epidemiological cutoff values for yeast-phase Talaromyces marneffei against six antifungal agents: a multicenter study in China
Kai-su Pan, Ying-gai Song, Sha Lu, Xiao-fang Li et al.
2026-09-02 · DOI: 10.1128/aac.00650-26Emergence of mutH V76G in carbapenem-resistant Klebsiella pneumoniae disrupts DNA mismatch repair and results in a hypermutator phenotype
Shaoji Cheng, Cornelius J. Clancy, Giuseppe Fleres, Hassan Badrane et al.
2026-09-02 · DOI: 10.1128/aac.00189-26In vitro activity of zoliflodacin against Neisseria gonorrhoeae collected in the United States from 2020 to 2022
Sarah M. McLeod, Samir H. Moussa, Meredith Hackel, Carmen Au et al.
2026-09-02 · DOI: 10.1128/aac.00527-26Emergence and local dissemination of NDM-14-producing Klebsiella pneumoniae ST147: a phylodynamic and epidemiological investigation
Gabriele Arcari, Mattia Carbotti, Riccardo Pavesi, Paolo Gigante et al.
2026-09-02 · DOI: 10.1128/aac.00545-26Oral lipid prodrug V2043 (1- O -octadecyl-2- O -benzyl- sn -glyceryl-P-remdesivir nucleoside) protects mice from lethal dengue infection
Alex E. Clark, Jonathan R. Erlich, James R. Beadle, Rachel E. McMillan et al.
2026-09-02 · DOI: 10.1128/aac.00401-26Penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis and the association with penicillin-binding protein mutations: a population genotypic and phenotypic study
Ouli Xie, Aimee Tan, Thanh Binh Nguyen, Andrew J. Hayes et al.
2026-09-02 · DOI: 10.1128/aac.00137-26Multilevel HierCC typing scheme for global genomic epidemiology and antimicrobial resistance surveillance of Campylobacter jejuni
Ruochen Wu, Sandeep Kaur, Michael Payne, Li Zhang et al.
2026-09-02 · DOI: 10.1128/aac.00310-26Antibacterial and antivirulence activities of abafungin against Clostridioides difficile : in vitro and in vivo studies
Ahmed A. Abouelkhair, Nader S. Abutaleb, Sahar Abdelrazek, Mohamed N. Seleem et al.
2026-09-02 · DOI: 10.1128/aac.00598-26Pharmacokinetics of injectable favipiravir: phase I, randomized, double-blind, placebo-controlled study in healthy East Asian subjects
Hiroshige Mikamo, Masahiro Nakabayashi, Tsutomu Sakurai
2026-09-02 · DOI: 10.1128/aac.00463-26Identification of a hypervirulent extensively drug-resistant ST383 Klebsiella pneumoniae sub-lineage carrying ICEKp5 in Lebanon
Martine Abboud, Tia Clara Chaaya, Yara Daccache, Nour El Alam et al.
2026-09-02 · DOI: 10.1128/aac.00384-26Reviews
Community Reviews
Version History
September 8, 2026 at 12:03 am
September 8, 2026